Technical Analysis for MDFZF - Medifocus Inc

Grade Last Price % Change Price Change
grade C 0.0093 -33.09% -0.0046
MDFZF closed down 33.09 percent on Friday, July 17, 2020, on 26 percent of normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Down
Historical MDFZF trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
50 DMA Support Bullish 0.00%
Wide Bands Range Expansion 0.00%
20 DMA Support Bullish -33.09%
Pocket Pivot Bullish Swing Setup -33.09%
Wide Bands Range Expansion -33.09%
20 DMA Support Bullish -23.14%
50 DMA Support Bullish -23.14%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -23.14%
Outside Day Range Expansion -23.14%
Older signals for MDFZF ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Medifocus, Inc. (TSXV-MFS, OTC-MDFZF) is a leader in the use of focused microwave energy to treat cancer and other tumors. It owns two fully developed technology platforms with comprehensive US and international patent protection: (1) The Endo-thermotherapy Platform-a catheter-basis focused heat technology platform that utilizes natural body openings to deliver precise microwave thermotherapy to the diseased sites. The U.S. FDA approved Prolieve Thermodilatation System for the treatment of Benign Prostatic Hyperplasia (?BPH?) was developed based on the Endo-thermotherapy and is currently generating revenue, and (2) The Adaptive Phased Array (APA) Microwave Focusing Platform-invented by MIT, licensed to Medifocus, directs precisely focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. The Company?s APA 1000 Breast Cancer Treatment System, developed from the APA technology platform has received approval from the U.S. FDA and Health Canada to conduct the pivotal Phase III clinical trials. The Company believes that these two technology platforms can provide the design basis for the development of multiple cancer treatment systems for surface, subsurface and deep seated localized and regional cancers.
Medicine Health Medical Specialties RTT Cancer Microwave Tumor Radiation Therapy Food And Drug Administration Fda Technology Platforms Catheter Tumors Benign Prostatic Hyperplasia Bph Mit Thermotherapy Treatment Of Benign Prostatic Hyperplasia

Is MDFZF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.0514
52 Week Low 0.0011
Average Volume 52,481
200-Day Moving Average 0.0183
50-Day Moving Average 0.0059
20-Day Moving Average 0.0094
10-Day Moving Average 0.0112
Average True Range 0.0055
ADX 20.02
+DI 28.1414
-DI 28.6649
Chandelier Exit (Long, 3 ATRs ) 0.0009
Chandelier Exit (Short, 3 ATRs ) 0.0183
Upper Bollinger Band 0.0169
Lower Bollinger Band 0.0019
Percent B (%b) 0.49
BandWidth 159.5745
MACD Line 0.0015
MACD Signal Line 0.0014
MACD Histogram 0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0185
Resistance 3 (R3) 0.0174 0.0134 0.0169
Resistance 2 (R2) 0.0134 0.0110 0.0139 0.0164
Resistance 1 (R1) 0.0113 0.0096 0.0124 0.0124 0.0159
Pivot Point 0.0073 0.0073 0.0078 0.0078 0.0073
Support 1 (S1) 0.0052 0.0049 0.0063 0.0063 0.0027
Support 2 (S2) 0.0012 0.0035 0.0017 0.0022
Support 3 (S3) -0.0009 0.0012 0.0017
Support 4 (S4) 0.0002